A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Topotecan (1,8)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subsequent treatment of platinum
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf

Topotecan (1,2,3,4,5)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3, 4, 5) Indication Second
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf

Etoposide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of recurrent platinum resistant ovarian
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Cyclophosphamide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CYCLOPHOSPHAMIDE ORAL Regimen Ovary – Cyclophosphamide Oral Indication Relapsed/refractory ovarian cancer in patients unsuitable for other treatments
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CyclophosphamidePO.pdf

Raltitrexed Ver 1.2

Description
Chemotherapy Protocol COLORECTAL CANCER Regimen RALTITREXED Colorectal Cancer– Raltitrexed Indication Treatment of metastatic / advanced colorectal cancer where fluorouracil and / or capecitabine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/RaltitrexedVer12.pdf

Panitumumab (21 day) Ver 1.1

Description
Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regimen Colorectal Cancer – Panitumumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

Fluorouracil Folinic Acid

Description
Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL and FOLINIC ACID (Modified de Gramont) Regimen • Colorectal Cancer– Fluorouracil and Folinic Acid (Modified de Gramont
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Folinic-Acid.pdf

ColorectalTrifluridineTipiricilVer1

Description
Chemotherapy Protocol Regimen COLORECTAL CANCER TRIFLURIDINE-TIPIRACIL  Colorectal Cancer – Trifluridine-Tipiracil Indication  Trifluridine-tipiracil is recommended as a third or subsequent
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/ColorectalTrifluridineTipiricilVer1.pdf

Cetuximab-Fluorouracil-Folinic Acid-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen • Colorectal Cancer – Cetuximab-Fluorouracil-Folinic Acid (modified de
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Belantamab Bortezomib Dexamethasone Weekly

Description
Chemotherapy Protocol BELANTAMAB MAFODOTIN – BORTEZOMIB - DEXAMETHASONE This protocol may require funding Regimen • Belantamab Mafodotin – Bortezomib - Dexamethasone Indication • 1 previous line of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Belantamab-Bortezomib-Dexamethasone-Weekly-Ver1.pdf
281 to 290 of 698
Previous … 27 28 29 30 31 … Next